Blog

A formulation team rarely loses control all at once. First, a chemist copies a recipe into a new spreadsheet because the original file is locked. Then a test result gets saved without the processing conditions that produced it. Later, a scale-up behaves differently, and nobody can confidently connect the production batch to the lab experiment that was supposed to guide it.

That's the moment to evaluate formulation development software, but not by counting dashboard features. The questions that matter are harder: Can your legacy data support reliable decisions? Can you verify why the software recommends a recipe, and when you should distrust it? A good purchase improves how your team learns, not just where it stores files.

Table of Contents

• When Spreadsheets Stop Scaling Your R&D Lab
• Four jobs the software must do

• Look past the polished import
• Make change history part of the evidence

• Separate prediction from recommendation

• Ask for evidence the team can inspect

• Pick a platform or a point solution deliberately

• Make each rollout phase prove readiness

When Spreadsheets Stop Scaling Your R&D Lab

The warning signs often appear during an ordinary project review. A formulation lead asks which version of a recipe went into testing, and three people offer three files. One spreadsheet records weight percentages, another uses parts by weight, and the test report names the sample by an internal code nobody recognizes outside the lab.

The team can still make progress, but every decision takes more manual reconstruction. A new chemist needs help tracing old experiments. A failed scale-up triggers a search through notebooks, email, instrument exports, and shared drives. The answer may be in there somewhere, but the evidence chain is incomplete.

Practical rule: If a scientist has to ask a colleague which file is authoritative, your data process already depends on undocumented knowledge.

These problems aren't a case for buying software just because spreadsheets are old. Spreadsheets remain useful for quick calculations and small, bounded tasks. They become a poor system of record when several people, sites, methods, and product versions need to maintain consistent links among recipe, material, process, and result.

Formulation development software should help a team decide what to test, preserve what happened, and make past work reusable. That requires more than a central folder or a polished experiment dashboard. Buyers should examine how the platform handles inconsistent historical records, tracks changes, and distinguishes a trustworthy recommendation from a guess.

Treat vendor demos as evidence-gathering sessions. Bring a messy example from your own program, such as a recipe with missing process conditions or different names for the same raw material. Ask the vendor to show how the system preserves the original record, flags what's unknown, and makes the result useful without disguising its limitations.

What Formulation Development Software Actually Is

A formulation is a system of interacting ingredients and process conditions. Changing one component can affect several properties, and the best recipe may depend on how the components behave together. Software built for this work needs to represent those relationships, not just collect test results.

The category has roots in Design of Experiments (DoE). Stat-Ease reports that its first Design-Ease version was completed in April 1985 and released in July 1985 as version 1.04 for DOS, supporting factorial design and analysis (Stat-Ease's history of Design-Expert). In 1988, Design-Expert added response-surface methods and mixture designs. Those methods fit formulation problems because ingredient proportions are constrained: raising one component often means lowering another. By 1996, Design-Ease capabilities had been consolidated in Design-Expert version 5 for Windows.

Four jobs the software must do

Quality by Design (QbD) extends this way of working into a risk-based approach that connects material attributes and process parameters to Critical Quality Attributes. In practice, formulation software should do four jobs:

1. Capture experiments consistently. Record recipe, raw-material identity, processing conditions, test method, result, and uncertainty in a linked structure.
2. Model recipe-to-performance relationships. Use statistical or domain-specific models to estimate how inputs relate to important outcomes, including interactions among variables.
3. Help choose the next experiment. Support planned designs and identify useful experiments within a defined design space, rather than encouraging unstructured trial and error.
4. Preserve usable knowledge. Keep formulation versions, data lineage, permissions, and the basis for analytical conclusions visible.

That combination sets the category apart from adjacent tools. An ELN is built to capture laboratory work, a LIMS helps manage samples and laboratory workflows, and a data lake stores information from different systems. Each may be part of the solution, but none automatically provides the specialized experimental design, mixture modeling, and recipe optimization that formulation work requires. A strong platform connects these systems while keeping the decision context intact.

Classical factorial, central-composite, and Box–Behnken designs help researchers estimate main effects, interactions, curvature, and response surfaces more efficiently than exhaustive testing. The practical point isn't to replace scientific judgment with a design template. It's to make the experiment plan and its assumptions explicit, so the team can see what it learned and where the design space still has gaps. A review of formulation development in the context of QbD discusses how this approach links experimentation, modeling, and quality decisions (QbD and formulation development).

Core Capabilities That Matter Most

A feature list tells you what a vendor built. Your evaluation should establish what decisions each capability supports, and whether it works with the records your scientists have.

Look past the polished import

Data unification isn't complete when a vendor loads a folder of spreadsheets. Ask the team to show how it handles unit conversions, missing metadata, alternate material names, and test methods that changed over time. A system should preserve the source record and make transformations traceable. Otherwise, “centralized data” can mean a centralized set of poorly understood assumptions.

ELN and instrument integration deserves the same scrutiny. A one-time CSV import can support a pilot, but it leaves scientists maintaining a manual handoff. Ask whether the vendor can map fields, retain identifiers, and support a repeatable connection to the ELN or instrument workflow you use. Then test an exception, not just the clean-path demo.

A useful model should show more than a predicted value. Scientists need to know which properties it estimates, what data supports the prediction, and whether the candidate sits within the model's experience. For experiment planning, check whether the software supports the designs your team needs and makes the rationale for a proposed trial understandable.

Make change history part of the evidence

Versioning matters for both recipes and the datasets used to train or evaluate models. If a material specification changes, the team should be able to distinguish the old formulation from the new one and understand which evidence applies to each. An audit trail should show who changed what and when, while access controls should protect sensitive work across groups and sites.

Materials-informatics research emphasizes FAIR data principles, persistent identifiers, rich metadata, standardized representations, and explicit uncertainty. It also warns that measurement bias can teach a model the wrong relationship, while high run-to-run variance can obscure useful signals (FAIR data and materials informatics). Use that as a test of the vendor's data layer: can it link processing, structure, properties, and performance, and can your team detect where the records aren't comparable?

How AI and Explainable Models Change the Equation

AI changes the value of formulation software only when it improves the next decision. A model that predicts a property can help screen candidates, but a prediction alone doesn't explain whether the team should trust it, what to test next, or why one formulation is favored over another.

Separate prediction from recommendation

A predictive model estimates an outcome from inputs. An optimization method searches for candidate inputs that might meet a target. They're related, but they aren't interchangeable. If a vendor demonstrates a recommended recipe, ask which model produced its predicted properties, how the search chose that candidate, and whether the candidate falls within the chemistry and process conditions represented in the data.

Explainability needs to be practical. A scientist should be able to inspect relevant drivers, review similar historical formulations, and see uncertainty or an applicability-domain warning. “The model says so” isn't a useful rationale for a formulation decision, particularly when several responses must be balanced.

Good AI doesn't ask scientists to surrender judgment. It gives them a better-grounded experiment to judge.

The human-in-the-loop workflow is the product: the system proposes a next experiment, explains why it could be informative, flags where it's extrapolating, and captures the outcome for future analysis. Scientists then decide whether the experiment makes chemical and operational sense. This is more useful than framing AI as an autonomous recipe generator.

For buyers, the key question isn't whether a platform has many models. It's whether those models are relevant to your materials, methods, and decisions, and whether the software makes their limits visible. Ask to review the model's inputs, intended use, validation approach, and behavior when data is sparse. A capable system should help your team distinguish a strong candidate from a familiar-looking result that rests on weak evidence.

Trusting AI Recommendations on Regulated Formulations

A confident prediction on a vendor slide isn't sufficient evidence for a regulated formulation or a scale-up-critical decision. Confidence scores can be misleading if they aren't calibrated, and a model can appear persuasive while operating outside the conditions represented in its training data.

Recent materials-AI reviews identify data quality, model generalization, interpretability, computational cost, and experimental validation as continuing barriers, particularly when models use sparse or biased data (review of materials-AI adoption barriers). One recent study of low-temperature sealing materials used laboratory and AI-generated data while acknowledging the need to assess differences between those data sources and reduce overfitting risks. That's a useful reminder: synthetic data may help, but it doesn't remove the need for realistic validation.

Ask for evidence the team can inspect

Before accepting a recommendation, require the vendor to show:

• Calibrated uncertainty: How do predicted confidence levels compare with observed outcomes?
• Applicability-domain checks: Does the system flag recommendations outside the chemistry, process window, or measurement conditions represented in its data?
• Relevant precedents: Can scientists inspect comparable historical formulations and the conditions under which they were tested?
• Causal rationale: What evidence supports the factors the model identifies as influential, and what does it merely correlate?
• Wet-lab confirmation: Does the workflow require experimental validation before a recommendation becomes a basis for a regulated or scale-up decision?

Also request documentation of model intended use, validation data, known limitations, and how performance is monitored as new results arrive. Test the model on a case with missing metadata or an unfamiliar material. A responsible platform should make uncertainty and missing context visible rather than presenting a clean answer regardless.

The decision rule is straightforward: use AI to prioritize and explain experiments, not to bypass scientific review. If a vendor can't show what the model knows, where it might fail, and how your team confirms its output, don't treat the recommendation as decision-grade evidence.

How to Evaluate Vendors and Procurement Criteria

Procurement checklists often give equal weight to every feature. Don't. Security, data ownership, integration, and traceability are table stakes for an enterprise platform. The differentiator is whether the system can turn your real experimental history into useful, explainable decisions without forcing scientists into a parallel workflow.

Pick a platform or a point solution deliberately

A point solution can make sense when your need is narrow, such as a defined optimization workflow that can work with existing data systems. A platform is more appropriate when several sites, teams, or tools need shared traceability from experiment planning through results and scale-up. Neither choice is superior. The wrong choice is buying a platform before you've identified who will maintain its data model, or buying a point solution that adds another disconnected record system.

For a broader procurement process, Wistec's practical guide to ERP selection offers a useful way to structure requirements and compare vendors against operational needs. Apply the same discipline here: give each finalist the same sample data, scenarios, and evaluation questions. Make them show how the software responds when the record is incomplete, the material name differs across sites, or a scientist needs to trace a recommendation back to its evidence.

Implementation and Migration Without the All-at-Once Trap

The biggest implementation risk is treating migration as a file-transfer exercise. Legacy records often differ in units, naming, test methods, and process detail. If those differences go unresolved, a new platform can make them easier to search without making them safe to compare.

Start with one product line or site and a defined set of decisions. Choose records that reflect the range of real data quality, not only the cleanest examples. Preserve source files, document transformations, and agree on controlled vocabularies for ingredients, properties, and process conditions before asking a model to learn from the collection.

Make each rollout phase prove readiness

• Ingestion: Confirm the selected records are present, identifiable, and linked to their source.
• Normalization: Reconcile units and terminology, retain test conditions, and flag missing information rather than filling gaps.
• Baseline analysis: Check whether the data supports a useful model and whether its performance changes across batches, laboratories, or time periods.
• Explainability review: Have scientists inspect the model's reasoning, uncertainty, and limitations against known formulation behavior.
• Scale-up connection: Establish how lab recommendations, production conditions, and quality results remain traceable as a formulation moves toward manufacturing.

Don't mark a phase complete because a dashboard looks populated. Ask for evidence: Can a chemist retrieve the original record? Can the team tell which values were transformed? Can they identify incompatible test conditions? Can they explain what data supports a model output?

The EU's Regulation 2025/2455 establishes a common chemicals data platform and requires data to be findable, accessible, interoperable, and reusable, supported by consistent formats and controlled vocabularies (EU Regulation 2025/2455). That makes semantic normalization more than a tidy-up task. Build it into migration governance, with clear ownership for vocabulary, provenance, and permissions. Add model-driven recommendations only after the data foundation can support a defensible comparison.

KPIs, ROI, and What Success Looks Like in Practice

A go-live date is not a result. Teams regularly declare success because records were imported and weekly logins look healthy, while chemists keep running the same experiments they always ran. Judge the deployment on two things: whether decisions changed, and whether the evidence behind them improved.

Three measures do most of the work. Experiment efficiency tracks failed experiments, repeated tests, and how many design cycles a project needs before the team can select a candidate. Time to scale-up measures the path from a lab formulation to a production-ready process, including the hours lost investigating why the two disagree. Knowledge reuse asks whether teams can apply past evidence across projects or sites, and whether a new scientist can find and interpret prior work without informal handoffs.

Add two metrics most scorecards skip. Data readiness: what share of migrated legacy records can a chemist retrieve with original test conditions, units, and provenance intact? If that share is low, every downstream efficiency gain is suspect. Recommendation traceability: for each model suggestion the team acted on, could the scientist see the supporting data, the uncertainty, and the reason the model ranked it? On regulated formulations, that question decides whether AI output belongs in a quality record at all. Track override rates too, and check whether scientists who ignored a recommendation turned out to be right.

Set a baseline before rollout and define how each metric will be calculated. Separate improvement caused by better data capture from improvement tied to model recommendations. Otherwise, the executive scorecard reports progress without showing what changed.

Polymerize reports that its customers see up to 50% fewer failed experiments within three months, alongside faster scale-up from lab to production and rapid ROI across materials R&D programs (Polymerize's reported customer outcomes). Treat that as a vendor-reported result, not a guarantee for your program. Ask how the outcome was measured, what counted as a failed experiment, and whether the work and data conditions resemble your own.

Build the cost side. Include implementation, data cleanup, integration, training, and ongoing administration, not just subscription fees. The Doczen guide to automation ROI offers a practical frame for putting costs and benefits in one business case. Then review the same measures with R&D and finance together, so the project is not judged against a savings estimate detached from laboratory reality.

A useful operating scenario is straightforward: a chemist searches prior experiments, sees which results match the current materials and test conditions, reviews an explainable model's recommendation, and chooses a lab experiment to confirm it. The team records the result in a form that informs later decisions. That is the scorecard test: can the platform make learning more traceable and reusable while helping scientists choose better next steps?

Polymerize connects experimental data across spreadsheets, ELNs, and other silos, while Polymerize Labs supports property prediction, formulation optimization, and explainable recommendations for materials R&D. If you're assessing whether your data and AI workflows are ready for that kind of use, visit Polymerize to explore the platform and discuss your requirements.